Company intelligence
Magnus
About Magnus
Magnus is a privately held medical device company driven to transform lives by restoring mental health. The company is a developer of brain stimulation technology for the treatment of neuropsychiatric disorders. Its first product is the SAINT® Neuromodulation System, granted Breakthrough Device Designation and 510(k) clearance by the U.S. Food & Drug Administration (FDA) in September 2022 for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode.
Verified activity
Signals from Magnus
3 published signals
Research & Knowledge
Magnus is currently enrolling for a clinical trial evaluating SAINT® as an investigational treatment for postpartum depression.
Reported by Magnus
Research & Knowledge
Magnus contributed to a new article in Science Magazine highlighting the use of noninvasive brain stimulation for women during pregnancy and postpartum.
Reported by Magnus
People
Magnus is looking to hire a Certified Coder or Coding expert for a critical needs project.
Reported by DLene Kolanek